Insurance
Shifting consumer behavior, insuretech, and a talent gap, just three factors impacting the insurance industry. Read about these, and much more, here.
Why risk and insurance demand professionalism
‘If we deliver our very best, while being open and honest, we build trust in our profession and serve the public better’
-
Five key roles shaping the future of insurance
The many changes affecting the insurance sector make it an exciting destination for graduates from a variety of backgrounds, so what are providers doing about it?
-
Diversity and disruption in insurance
Ahead of Insurtech Insights Europe next month, Bradley Collins and Ellenie Chan call for a fresh approach to hiring and people management to supercharge disruptive growth in the insurance industry
-
What is being done to protect freelancers?
The exponential rise of the freelance workforce is a much-discussed trend across the globe, but is enough being done to protect those who don't have cover?
-
Why insurers need to invest for the planet
Insurers are starting to feel the pressure over climate change, not just as companies pay up when catastrophes hit, but also as the spotlight turns to insurance investment management
-
How driverless cars will affect insurance
How driverless technology will affect the car insurance industry remains uncertain, but there is no doubt providers will have to adapt
-
How Coronavirus is rattling travel insurance
The coronavirus outbreak has raised questions in the insurance industry for both travellers and insurers alike
-
Why buyers’ clubs are the last option for desperate families
How an ongoing pricing battle between the NHS and an American biopharmaceutical giant led to a buyers’ club for cystic fibrosis drugs in the UK
Insurance Infographics
-
How blockchain will revolutionise insurance
How an ongoing pricing battle between the NHS and an American biopharmaceutical giant led to a buyers’ club for cystic fibrosis drugs in the UK
-
Five questions shaping driverless car insurance
How an ongoing pricing battle between the NHS and an American biopharmaceutical giant led to a buyers’ club for cystic fibrosis drugs in the UK
-
Insurance needs a major rebrand to attract new talent
How an ongoing pricing battle between the NHS and an American biopharmaceutical giant led to a buyers’ club for cystic fibrosis drugs in the UK
-
What AI can do for the insurance industry
How an ongoing pricing battle between the NHS and an American biopharmaceutical giant led to a buyers’ club for cystic fibrosis drugs in the UK